NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bright Path Laboratories

Bright Path Laboratories

Private
Kannapolis, North CarolinaHealthcare & Life Scienceshttps://brightpathlabs.com/

Last Round

Grant

Aug 28, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bright Path Laboratories is a pharmaceutical technology company that provides development and manufacturing of Active Pharmaceutical Ingredients (APIs) and related precursors using advanced continuous manufacturing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Pharma Supply Chain, Defense Tech

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

continuous manufacturingactive pharmaceutical ingredientsAPICDMOcontract development and manufacturingmodular manufacturingpharma supply chainprocess intensificationreshoringagile manufacturingdefense techbiotech manufacturingsmart manufacturingflow chemistrypharmaceutical automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bright Path Laboratories Comparables

Compare Bright Path Laboratories with similar companies based on industry and business-model similarity.

Bright Path Laboratories comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
On Demand Pharmaceuticals
90%
CONTINUUS Pharmaceuticals
88%
Phlow Corp.
87%

Bright Path Laboratories Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 28, 2024

Key People

Founding team and executive leadership

Tony Quinones

CEO

Executive Team

Jerry Irwin

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 31% MoM, reaching 2.5K.

  • Oct 15, 2025

    Grew 28% QoQ, from 25 to 32 employees.

Bright Path Laboratories Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bright Path Laboratories Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bright Path Laboratories's valuation, stock price, and market status.

Firmographic Details

HeadquartersKannapolis, North Carolina
Employee Range36
Year Founded2019
Last FundingAug 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.